Khashayar Farsad, MD, PhD (he/him/his)

Professor
Oregon Health and Science University, United States

Presentation(s):

• Randomized Embolization Trial for NeuroEndocrine Tumors (RETNET)

  Sunday, March 30, 2025
  3:54 PM – 4:03 PM CT

• Are you ready to become a department as an IR service in your own hospital?

  Sunday, March 30, 2025
  4:45 PM – 5:45 PM CT

• 48 - Lipiodol-Mediated Potentiation of Cell Apoptosis by External Beam Radiotherapy: In Vitro Study

  Monday, March 31, 2025
  12:10 PM – 1:10 PM CT

• Portal Hypertension 2

  Monday, March 31, 2025
  3:00 PM – 4:30 PM CT

• CLIF-C AD and MELD 3.0 Provide Better Prognostic Value in Emergency TIPS than MELD and MELD-Na: Single-Site Retrospective Analysis

  Monday, March 31, 2025
  3:27 PM – 3:36 PM CT

• Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Combined with MELD 3.0 as a Prognostic Predictor for Patients with Liver Cirrhosis Undergoing Transjugular Intrahepatic Portosystemic Shunt (TIPS) Creation

  Monday, March 31, 2025
  4:03 PM – 4:12 PM CT

• Diagnostic Challenges to NCPH

  Tuesday, April 1, 2025
  9:00 AM – 9:15 AM CT

• Case 1

  Tuesday, April 1, 2025
  4:15 PM – 4:25 PM CT

• How to build a service line: example is the Portal Hypertension Center of Excellence

  Tuesday, April 1, 2025
  4:45 PM – 5:45 PM CT

• Catheter-directed organ-targeting immune augmentation using a nanoparticle-based therapeutic in a rat de novo HCC model.

  Wednesday, April 2, 2025
  8:00 AM – 8:07 AM CT

• TIPS is not an option in patients with high MELD/APACHE scores pro vs con

  Wednesday, April 2, 2025
  10:00 AM – 10:22 AM CT

• Enhanced Local Drug Accumulation via Intra-Arterial Administration of Magnetic Nanoparticles and Hyperthermia Induced Antitumor Effects in a Rat Pancreatic Cancer Model

  Wednesday, April 2, 2025
  10:30 AM – 10:39 AM CT